The QualityStocks Daily Newsletter for Thursday March 4th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


OTC Reporter (GWTR)


Cool Penny Stocks (TIVO)


Gusher Stocks (CNAM)

The QualityStocks Daily

Tombstone Technologies, Inc. (TMCI)

We are highlighting Tombstone Technologies, Inc. (TMCI) as "One to Watch", here at the QualityStocks Daily Newsletter.

Tombstone Technologies, Inc. is a software development company focused on delivering Web-to-Print solutions to the print industry. The Company’s graphic design tools are leading the emerging market for automated custom image applications. Formed in 2005, the Company trades on the OTC Bulletin Board. They have their corporate headquarters in Longmont, Colorado.

Tombstone Technologies, Inc. designed their first product, OIEPrint™ (patent pending), for use by anyone with the capability to take high-resolution digital designs and put them to work. OIEPrint™ is a customizable, template driven Web-to-Print design tool. It allows non-professionals to get professional results without investing time in overcoming a learning curve.

OIEPrint is for designing almost anything that is printable. Tombstone Technologies, Inc. can design a format or visual representation that can find use to create an enterprise’s products. This can be letterhead, brochures, baseball caps, t-shirts, rack cards, and more.

The OIEPrint Suite is available as Software as a Service (SaaS). The Company will manage all aspects of the installation for an enterprise from their servers. In addition, they provide a Web-based tool for a user to access all components of OIEPrint Site from their desktop. In this way, they can add products, change prices, and get the sales reports that they require.

The OIEPrint Suite is a complete ecommerce system. A user can set up their online store from the Company’s secure Control Panel. They can also track orders, process payments, view customer histories, and create their own templates. OIEPrint Suite allows an enterprise to put their print shop directly on the Internet. Therefore, they can compete with print shops worldwide.

OIEPrint store is the ecommerce component of the product suite. It allows enterprises to offer their customers the ability to manage their accounts online, create orders and reorders, and get online quotes. It is customizable and designed to handle complex print jobs.

On January 19, 2010, Tombstone Technologies, Inc. announced that they entered into an agreement to acquire the assets of Hunt Global Resources, Inc. The transaction is in the form of a reverse acquisition – Hunt Global Resources will be a wholly owned subsidiary of Tombstone Technologies. Hunt Global Resources, Inc. is a Houston-based company focused on the use of new technologies to maximize the value of their natural resources projects.

We have Tombstone Technologies, Inc. (TMCI) locked on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Tombstone Technologies, Inc. (TMCI) closed today at $1.00 on no volume.

GuestLogix Inc. (GXI.TO)

Today we are highlighting GuestLogix Inc. (GXI.TO), here at the QualityStocks Daily Newsletter.

GuestLogix Inc. is the world's leading onboard store technology provider to the airline industry. Trading on the Toronto Stock Exchange, the Company helps airlines build and manage onboard retail operations tailored to their needs and their passengers. They serve 35 percent of global airline passenger traffic. GuestLogix Inc. has their headquarters in Toronto, Ontario. They also have regional offices in Washington, DC, High Wycombe, UK, and Singapore.

Founded in 2002, GuestLogix Inc.'s corporate mission is to deliver innovative, end-to-end solutions that create new revenue streams and growth while enhancing service. The Company's clients include leading airline brands such as American, Delta, US Airways, United, Southwest, Ryanair, Brussels Airlines, and Germanwings. GuestLogix' onboard transaction platform is the effective standard in the airline sector representing agreements to serve over 800 million passenger trips annually.

GuestLogix Inc. believes that to get to the next level in onboard retail, operators need to think about serving the 'audience of one.' This is an approach widely used by the most successful retailers. GuestLogix calls this onboard retailing concept 'Passenger-Centric Merchandising'.

They believe that because passenger motives and onboard buying behaviors represent the single most significant differences between onboard retailing and traditional retailing, operators can most effectively serve each passenger or 'audience of one' by focusing their merchandising efforts. Operators are increasingly recognizing that direct to passenger selling during flight has the potential to be very lucrative. This is because they have a captive audience onboard.

GuestLogix believes that improved execution of existing onboard processes can also garner significant returns, while new onboard retailing initiatives are quickly taking hold. GuestLogix has shown that it can increase sales by 20 percent to 30 percent alone by facilitating onboard cash management in any currency, credit, and debit cards, with their retail platform.
On March 2, 2010, GuestLogix Inc. announced that they are deploying their point-of-sale handhelds and onboard retail technology with ExpressJet Airlines, the Express partner of Continental Airlines headquartered in Houston, Texas.

GuestLogix Inc. (GXI.TO) closed Thursday's trading session at $1.81 up 6.47 percent. Volume was 752,093.

Geron Corporation (GERN)

Greenbackers and SmallCap Voice reported recently on Geron Corporation (GERN), Momentum Trades, Investment U, OTC Advisors, Hit and Run Candle Sticks, Today's Financial News, Penny Sleuth, SpeculatingStocks.com did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Geron Corporation is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. These include spinal cord injury, heart failure, and diabetes. Incorporated in 1990, Geron has been in business since 1992. Geron Bio-Med Limited is the Company's wholly owned subsidiary located in Edinburgh, Scotland. TA Therapeutics, Limited is their majority-owned subsidiary located in Hong Kong. Geron Corporation has their headquarters in Menlo Park, California.

Geron Corporation is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. They also engage in the development of human embryonic stem cell-based therapeutics. They have received FDA clearance to begin the world's first human clinical trial of a hESC-based therapy: GRNOPC1 for acute spinal cord injury. Geron bases their product development programs upon three patented core technologies. These are telomerase, human embryonic stem cells, and nuclear transfer.

The Company and their collaborators have shown that telomeres, located at the ends of chromosomes, are key genetic elements involved in the regulation of the cellular aging process. For human embryonic stem cells, Geron intends to use human embryonic stem cell technology to enable the development of transplantation therapies. This is by providing standard starting material for the manufacture of therapeutic cells and facilitating pharmaceutical research and development practices by providing cells for disease models and screening, and for assigning function to newly discovered genes.

In 1999, Geron acquired Roslin Bio-Med Ltd. With this acquisition, they acquired an exclusive license to the patents for nuclear transfer technology. This is for multiple applications in animal and human biology. In 2005, they formed a joint venture with Exeter Life Sciences, Inc., called Start Licensing, Inc., a company to manage and license a broad portfolio of intellectual property rights related to animal reproductive technologies, including the full range of applications for nuclear transfer. In 2008, they merged Start Licensing, Inc., with ViaGen, Inc., a leading animal genomics and livestock-cloning firm, to create a one-stop licensing and operating company.

In January 2010, Geron Corporation announced that they entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant. This collaboration is to investigate the therapeutic potential of their human embryonic stem cell (hESC)-based product, GRNOPC1, for Alzheimer's disease. The Company is currently developing GRNOPC1 for the potential treatment of spinal cord injury.

Yesterday, Geron Corporation announced that Corning Incorporated launched the Synthemax™ surface. This is a new synthetic matrix for growing human embryonic stem cells (hESCs), developed under a collaboration and license agreement between the two companies. Geron and Corning have been working together to develop synthetic surface matrices to enhance the scalability of hESC-derived product manufacturing. The Corning® Synthemax™ surface is the first such product to undergo commercialization.

Geron Corporation (GERN) closed Thursday's session at $6.01 up 3.09 percent. Volume was 1,289,499.

SORL Auto Parts, Inc. (SORL)

Recently, Cool Penny Stocks Reported on SORL Auto Parts, Inc. (SORL), MicroCap Gems, Greenbackers did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

SORL Auto Parts, Inc. is a leading manufacturer and distributor of commercial vehicle air brake systems as well as related auto parts in China. The Company ranks first in market share in the segment for commercial vehicles weighing more than three tons, such as trucks and buses. They distribute products within China and internationally under the SORL trademark. SORL Auto Parts, Inc. trades on the NASDAQ Global Market and they have their corporate headquarters in Zhejiang, China.

SORL, through their 90 percent ownership of the Ruili Group Ruian Auto Parts Co., Ltd., a Sino-foreign Joint Venture, develops, manufactures and distributes automotive air brake valves and related components to automotive original equipment manufacturers (OEMs), and the related aftermarket. Installed on the chassis, air brake valves include a collection of various air brake components using compressed air and functioning as the execution device for service braking and parking braking.

The Joint Venture is the largest commercial vehicle air brake system manufacturer in China. The Joint Venture has established sales networks of 28 authorized distributors covering the seven regions nationwide. The 28 authorized distributors sell only "SORL" products and channel the products through over 800 sub-distributors.

SORL ranks among the top 100 auto component suppliers in China. The Company's product range includes 40 types of air brake valves and over 1,000 different specifications. They have four authorized international sales centers in Australia, United Arab Emirates, India, and the United States. In addition, they have more offices slated to open in other locations in the near future.

In January 2010, SORL Auto Parts Inc. announced that they entered into two new agreements to better penetrate the agricultural, light truck, and alternative energy vehicle segments in China. The Company's management reached a preliminary agreement to form a strategic alliance with the Shandong Shifeng Group. Shandong Shifeng Group intends to increase their purchases of brake systems and related products from SORL during 2010. Shandong Shifeng also plans to implement new joint product development programs with SORL to enhance Shifeng's agricultural vehicles and light truck production.

On February 4, 2010, SORL Auto Parts, Inc. announced that they entered into definitive agreements to sell 1,000,000 shares of their common stock to select institutional investors at a price per share of $10.00 pursuant to a registered direct offering. This transaction will represent gross proceeds of approximately $10 million. The Company intends to use all of the net proceeds for general corporate and working capital purposes.

SORL Auto Parts, Inc. (SORL) closed Thursday's trading session at $8.80 up 0.46 percent. Volume was 78,474.

Blue Coat Systems Inc. (BCSI)

Today, All about Trends reported on Blue Coat Systems Inc. (BCSI), Internet.com did recently. Earlier, The Best Newsletters, Investment House, The Tycoon Report, and Silicon Investor reported on the Company, and we do as well, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ, Blue Coat Systems Inc. is the technology leader in Application Delivery Networking (ADN).  The Company offers an Application Delivery Network Infrastructure that provides the visibility, acceleration, and security required to optimize and secure the flow of information to any user, on any network, anywhere. Founded in 1996, Blue Coat Systems Inc. has their headquarters in Sunnyvale, California.

The Company's application intelligence enables enterprises to align network investments with business requirements, speed decision-making, and secure business applications for long-term competitive advantage. Blue Coat provides the ADN infrastructure to more than 15,000 customers globally. This includes 81 percent of the Fortune® Global 500. They also maintain support centers in Sunnyvale, London, Tokyo, Kuala Lumpur, Waterloo, and Dubai.

The Application Delivery Network infrastructure addresses the demand for greater application mobility and security in a distributed enterprise. The Company's three core capabilities - Application Performance Monitoring, WAN Optimization, and Secure Web Gateway technologies - when deployed together, enable the ADN. These three core capabilities provide visibility to classify and prioritize applications, content, and user access in real time.

They also provide acceleration of internal, external, and real-time applications across the distributed enterprise. Additionally, they provide security of people and information from malicious applications, content, and intent.

Last month, Blue Coat Systems Inc. said that their fiscal third-quarter net income increased more than six-fold despite a significant restructuring charge. Earnings for the three months ended Jan. 31 rose to $6.9 million, or 15 cents per share, from $1.1 million, or 2 cents per share, in the same period last year. Excluding a $9.1 million restructuring charge and other special items, Blue Coat said they earned 37 cents per share. Revenue grew 16 percent to $127.1 million from $109.6 million in the year-ago quarter.

This week, Blue Coat Systems, Inc. is demonstrating how the on-demand security intelligence of their Secure Web Gateway solution provides proactive layers of defense against new and evolving Web-based threats. They are demonstrating this at RSA Conference 2010, March 1-5, in San Francisco, California. On Friday, March 5, 2010, Blue Coat Senior Malware Researcher Chris Larsen will break down recent real-world attacks to examine how link farms, botnets, and gray search engines are used to create multi-staged attacks.

Blue Coat Systems Inc. (BCSI) closed today's trading session at $30.00 down 0.63 percent. Volume was 425,032.

Antigenics Inc. (AGEN)

Greenbackers, Wall Street News Alert, Momentum Traders, OTC Picks, Cool Penny Stocks, HotOTC.com, Mr. Liquid, Hit and Run Candle Sticks, Stock Rich, Stock Egg, Penny Invest, Monster Stock Alerts, Stock Fortune Teller, and Stock Spice reported earlier on Antigenics Inc. (AGEN), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Antigenics Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The lead products in development at Antigenics are Oncophage®, AG-707, and QS-21. The Company has corporate offices in New York City, and research, development and manufacturing facilities in Lexington, Massachusetts. They trade on the NASDAQ Capital Market.

In April 2008, Oncophage® (vitespen; heat shock protein technology), received approval in Russia for the treatment of kidney cancer patients at intermediate risk for disease recurrence. Outside of Russia, Oncophage is an investigational patient-specific vaccine designed to treat cancer with the intent of minimizing side effects. Oncophage® is currently undergoing evaluation in clinical trials. Treatment with Oncophage is designed to target only cancerous cells, not healthy normal cells. Consequently, Oncophage is designed to limit the toxicities associated with traditional broad-acting cancer treatments.

AG-707 is an investigational vaccine for genital herpes treatment. It is based on proprietary heat shock protein technology. This off-the-shelf formulation has completed Phase 1 testing. QS-21 is one of the world's most widely studied immune adjuvants. This investigational adjuvant is undergoing testing in several advanced clinical vaccine programs in partnership with leading pharmaceutical companies.

Antigenics Inc. has achieved significant milestones in their history. The Company advanced six products in clinical trials, including Phase 3 trials, and built on five technology platforms. They also established a strong intellectual property position in their core technologies, with more than 80 issued U.S. patents.

In 2009, Antigenics received European orphan drug designation from the EMEA in glioma, providing the Company with 10 years of potential market exclusivity if the product is approved for marketing in the EU. Antigenics also received orphan drug status from the FDA for Oncophage in glioma. This provides the Company with potential market exclusivity for seven years from FDA marketing approval. Oncophage was also named the "best therapeutic vaccine" by the World Vaccine Congress.

Also in 2009, survival data from an interim analysis of the global patient survival registry showed that patients with kidney cancer at intermediate risk of disease recurrence had approximately a 46 percent lower risk of death when treated with Oncophage. A promising trend for overall survival was shown in patients treated with Oncophage in the total population eligible for the study.

Approximately 15 vaccines containing Antigenics' QS-21 investigational adjuvant are in clinical-stage development. These are by partners such as GlaxoSmithKline. Phase 3 programs include vaccines for malaria, melanoma, and non-small cell lung cancer.
Antigenics Inc.
(AGEN) closed Thursday's session at $0.7598 down 0.03 percent. Volume was 210,011.

ADVENTRX Pharmaceuticals, Inc. (ANX)

Recently, Greenbackers, The Street, HotOTC.com, Cool Penny Stocks, Stock Rich, and The Bull Report reported on ADVENTRX Pharmaceuticals, Inc. (ANX), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the NYSE: Amex, ADVENTRX Pharmaceuticals is a biopharmaceutical company. Their focus is on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. The Company works to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens. Founded in 1995, ADVENTRX Pharmaceuticals, Inc. has their corporate headquarters in San Diego, California.

The Company is focusing currently on commercializing two late-stage product candidates in the U.S. One is the ANX-530 (vinorelbine emulsion), a novel emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin. This product candidate is also to treat advanced or metastatic breast cancer.

Their other late-stage product candidate is ANX-514 (docetaxel emulsion). This product candidate is a novel emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. Both ANX-530 and ANX-514 are reformulations of currently approved products.

On March 1, 2010, ADVENTRX Pharmaceuticals, Inc. announced that they received a refuse to file letter from the U.S. Food and Drug Administration (FDA). This is regarding the Company's New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion).  The FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially viable expiration-dating period.  FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. 

ADVENTRX Pharmaceuticals, Inc. plans to meet with the FDA as soon as possible to discuss their response. ADVENTRX submitted the NDA for ANX-530 on December 30, 2009. 

 "We will work closely with the Agency to understand its new requirements and define the path to a successful resubmission at the earliest possible time," said Mr. Brian M. Culley, Chief Executive Officer at ADVENTRX Pharmaceuticals, Inc.

Today, ADVENTRX Pharmaceuticals, Inc. (ANX) closed at $0.2249 up 7.61 percent. Volume was 11,585,617.

Belltower Entertainment Corp. (BTOW)

Today we choose to highlight Belltower Entertainment Corp. (BTOW), here at the QualityStocks Daily Newsletter.

Belltower Entertainment Corp. is a fully integrated film entertainment company. The Company creates favorable studio participation for distribution and P&A funding with critically acclaimed screenwriters and top talent attachments. Trading on the OTC Bulletin Board, Belltower Entertainment Corp. has their headquarters in Los Angeles, California. They also have a satellite office in Shanghai, China complemented by strategic production and finance partners globally.

The Company focuses on securing ownership of film projects to be developed and packaged in-house, which attract premier production and acting talent, while keeping costs down through tax friendly production territories and other soft money avenues. Their focus is on Asia and Latin America.

In January 2010, Belltower Entertainment announced that Giovanni Ribisi (Avatar, Gone in Sixty Seconds, Boiler Room) is set to star as legendary golfer Moe Norman in Dance the Green written by Academy Award winner Barry Morrow (Rainman) and to be directed by Ericson Core (Invincible). Belltower Entertainment is financing the picture budgeted at US$10 million, and shooting of the film is to start in late spring.

Today, Belltower Entertainment Corp. announced that they partnered with Amalgamation Entertainment, based in Atlanta, Georgia. This is to co-finance the feature film currently entitled Little Treasure starring Academy Award winner Forest Whitaker (Last King of Scotland). In addition, Whitaker will serve as Executive Producer on the film. Pre-production has officially commenced with filming set to start April 5th, 2010. Belltower and Rouge Entertainment are currently in negotiations with foreign sales distributor Fortissimo to handle all foreign territory sales for Little Treasure.

Belltower has two more feature films that are currently in various stages of development and pre-production. These two films are on the Company's production schedule for 2010. The Company maintains copyright ownership in all three films slated for production this year. In addition, they have majority control over production, financing, and distribution.

Belltower Entertainment Corp. (BTOW) closed Thursday's session at $0.35 up 40.00 percent. Volume was 30,000.

The QualityStocks Company Corner

WikiLoan, Inc. (WKLI)

The QualityStocks Daily Newsletter would like to spotlight WikiLoan, Inc. (WKLI). Today, WikiLoan, Inc. closed trading at $0.5350, which was up 25.59 percent. Their volume today was 5,176,016 shares – a new all-time record.

WikiLoan, Inc. (WKLI) announced that they successfully renegotiated with their contracted processor for dramatically lower ACH fees for WikiLoan user payments.

WikiLoan, Inc. (WKLI) operates a Social Network with a focus on finance. At WikiLoan.com, family and friends can borrow and lend money among themselves at rates suitable to their respective needs. The website provides repayment schedules and documentation for loans, along with proprietary administrative tools, enabling users to securely pull credit reports and automate the loan repayment process.

Through a simple process, borrowers can create a loan listing between $1,000 and $25,000. They set the rate they are willing to pay for the loan, get their WikiScore, and invite friends in their network to view the listing. Lenders then receive an invitation to view the listing and are provided with the borrower’s WikiScore, debt-to-income ratio, and the loan repayment schedule.

Once the loan is fulfilled, WikiLoan compiles the promissory note and provides it to all involved parties. The company also handles on-going notifications and provides access to online payment systems to ensure a smooth repayment process. Wikiloan generates revenues through fees for documentation, credit score checks and administrative services.

The market opportunity for WikiLoan is significant considering the ongoing financial crisis, bank consolidations and changing consumer behavior with regards to online lending, borrowing and banking. In the midst of current economic conditions, peer-to-peer lending has become one of the fastest growing sectors of the financial services industry and WikiLoan is well positioned to capitalize on its ongoing growth. Disclaimer

WikiLoan, Inc. Blog

WikiLoan, Inc. News:

WikiLoan Renegotiates ACH Fees

WikiLoan Signs Major Deal - Sales May Top $20 Million

WikiLoan Close to First Deal

Cityside Tickets, Inc. (CIST)

The QualityStocks Daily Newsletter would like to spotlight Cityside Tickets, Inc. (CIST). Today, Cityside Tickets, Inc. closed trading at $0.28, which was down 16.67 percent. Their volume today was 1,133,451 shares.

Cityside Tickets, Inc. (CIST) announced that CEO Michael DeAmicis" interview with FOX Business is now available online at www.Video.QualityStocks.net.

Cityside Tickets, Inc. (CIST) offers a diverse range of tickets for sale through their website at www.citysidetickets.com. In addition, visitors to the company’s website can use the site to sell tickets they have available. Cityside Tickets’ focus is on offering tickets to quality theatre acts in a variety of cities.

The company offers concert tickets, theatre tickets, and sports tickets to their customers. Currently, Cityside Tickets is offering concert tickets for acts such as Taylor Swift, Bon Jovi, Lady Gaga, and Elton John & Billy Joel, to name a few. For Theatre tickets, the company is offering tickets for Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, among others.

Cityside Tickets also offers tickets to Major League Baseball, NBA Basketball, NFL Football, and NHL Hockey events. They also offer Monster Jam tickets, National Finals Rodeo tickets, Ultimate Fighting Championship tickets, U.S. Open Tennis Championship tickets, and WWE-World Wrestling Entertainment tickets.

Additionally, Cityside Tickets offers tickets to NASCAR racing events. This includes tickets to the Daytona 500 at Daytona International Speedway as well as the Atlanta Motor Speedway, Darlington Raceway, Indianapolis Motor Speedway, Michigan International Speedway, Pocono Raceway, and Watkins Glen International. This is in addition to a host of other racetrack offerings presented on the company’s web portal. Disclaimer

Cityside Tickets, Inc. Blog

Cityside Tickets, Inc. News:

CitySide Tickets, Inc. CEO to Be Interviewed on FOX Business Network Live

CitySide Tickets, Inc. Featured in Boston Herald

CitySide Tickets, Inc. Signs Letter of Intent for 100% Ownership in Ticket Broker StadiumTickets.com

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT). Today, Newport Digital Technologies, Inc. closed trading at $0.0180, which was up 9.09 percent. Their volume today was 3,595,999 shares.

Newport Digital Technologies, Inc. (NPDT) announced that they developed and launched their first leading-edge LED digital signage solution that offers wireless high definition video and audio streaming that is compatible with 3G networks such as AT&T and Wi-Fi and WiMax networks.

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Message Board

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

CORRECTING and REPLACING Newport Digital Technologies Develops First LED Digital Signage Solution with Wi-Fi, 3G and WiMax Wireless Connectivity

Newport Digital Technologies Provides Update on Launch of N37B Rugged Handheld With Microsoft Windows and AT&T 3G Network Connectivity Through Ingram Micro

Newport Digital Technologies, Inc. Announces the Appointment of Leonard Makowka M.D. Ph.D. to the Advisory Board

Energtek, Inc. (EGTK)

The QualityStocks Daily Newsletter would like to spotlight Energtek, Inc. (EGTK). Today Energtek, Inc. closed trading at $0.25, which was down 10.71 percent. Their volume today was 167,335 shares.

Energtek, Inc. (EGTK) announced that their fully owned subsidiary, Energtek Philippines Inc., received certification as a duly accredited participant in the Filipino Natural Gas Vehicle Program for Public Transport (NGVPPT).

Energtek, Inc. (EGTK) is focused on developing and commercializing Adsorbed Natural Gas (ANG) technology. This tecshnology enables the storage of comparable gas quantities at reduced pressure, dramatically decreasing the capital investment and operational costs of natural gas vehicles. The company recognizes the global markets' demands to diversify energy sources and is working on breakthrough technologies that deliver natural gas to the consumer, even where no gas pipeline and compressing infrastructure exist.

Because natural gas is cheaper, cleaner and available in greater quantities than oil, Energtek believes it is the most practical motor fuel alternative. Natural gas is primarily comprised of methane, which is one of the simplest and most abundant substances found in nature, especially when compared to oil. Taking advantage of natural gas resources located across the globe will also reduce the number of countries forced to import motor fuel, including the USA.

The percentage of Natural Gas Vehicles (NGVs) in many countries is growing rapidly. Today, there are more than 8.7 million NGVs on the road, a number that is growing by more than 30% per year. Even with this robust growth, NGVs still represent only a small percentage of the overall vehicle market. Until now, costly refueling infrastructure, as well as the inconvenience of integrating NG tanks into vehicles, has limited the growth of NGVs. However, by enabling the use of natural gas in places previously impossible, Energtek's proprietary ANG technology promises to greatly expand the NGV market.

CEO Lev Zaidenberg leads the company with extensive experience starting and managing several successful hi-tech companies in Israel, Europe and the USA. Mr. Zaidenberg received a B.Sc. in Applied Mathematics and an MBA from Tel-Aviv University. Professor Yuri Ginzburg serves alongside Zaidenberg with a PhD / D.Sc in Mechanical Engineering and a comprehensive background in the automotive industry. Ginzburg is a specialist in alternative fuel systems and R&D projects management, and has authored 18 patents and over 70 scientific works. Disclaimer

Energtek, Inc. Company Blog

Energtek, Inc. News:

Energtek Completes Production of World's First LMP(TM) Low-pressure Semi-Trailer

Energtek Identifies Commercial Consumer for Natural Gas Extracted on Site in Israel

Energtek Anticipates Increase of NatGas Activities in India and FMC Technologies Awarded $30 Million Contract for StatoilHydro's Peregrino Project

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0132, which was down 5.71 percent. Their volume today was 304,321 shares.

Consorteum Holdings, Inc. (CSRH) announced that Mr. Pat Donahue will join the Company's new Board of Advisors. Mr. Donahue's past leadership positions include Chairman and CEO of McDonald's Canada and Chairman and CEO of McDonalds Japan.

Consorteum Holdings, Inc. (CSRH) is focused on providing financial services, electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. The company’s services provide customized, innovative technology solutions that create, augment and enhance their clients’ existing financial, payment and transactional processing systems.  

The company offers clients a long-term strategic plan utilizing the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create exceptionally customized programs. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new revenues. 

Consorteum’s strategy is to capitalize on the global opportunities within the growing financial services, payment and transaction processing marketplace. The utilized business model generates revenues on every transaction touched, thus providing long-term, sustainable income. The company has strategically designed its business initiatives to create significant repetitive transactions on an ongoing basis. Additional company revenues are generated from consulting services, project minimums and management fees. 

The company is jointly led by CEO Craig Fielding and President & COO Quent Rickerby. Mr. Fielding brings a wealth of expertise in the payments industry, in both local and international payment processing, along with HR-specific business management expertise, leadership, customer development and acquisition skills. Mr. Rickerby brings over two decades of business management, international and domestic sales experience, new company start-up, payment processing, project management, business development, negotiations, relationship management and strategic company direction.Disclaimer

Consorteum Holdings, Inc. Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Inc. Appoints Past Chairman & CEO of McDonald's Japan to Board of Advisors

Consorteum Holdings Inc. Launches International Payroll and Multi-Currency Service

Consorteum Holdings Inc. Signs Contract with UK Based Staffing Company Blue Sea Manning Ltd.

Energtek, Inc. (EGTK) Acquires Accreditation from Philippines Department of Energy

Energtek Inc., a world leader in the development of Adsorbed Natural Gas (ANG) technology, announced that its fully-owned subsidiary, Energtek Philippines Inc., has been certified as a duly accredited participant in the Filipino Natural Gas Vehicle Program for Public Transport (NGVPPT).
The official Certificate of Accreditation was issued by the Filipino Department of Energy. Through the accreditation Energtek Philippines Inc. is entitled to convert and retrofit existing vehicles to operate on Natural Gas, as well as provide ongoing Natural Gas supply to the vehicles as fuel. According to the press release, the certification was issued after extensive field trials of the company’s CNG Lite(TM) fuel system for small vehicles.

The company’s CNG Lite(TM) system for small vehicles is particularly suitable for gasoline-powered tricycles, which represents one of the most popular forms of transportation in the Philippines. There are millions of these tricycles in the Metro Manila area, contributing to dangerous pollution levels.

The provision of gas through the NGVPPT program will allow the conversion of large numbers of gasoline powered tricycles to operate on Natural Gas, significantly reducing the nation’s dependence on foreign oil as well as pollution levels. CNG Lite(TM) is currently the only commercially-viable system that can be utilized for mass conversions of tricycles in the Philippines.

“NGVPPT accreditation is a major step for Energtek,” stated Energtek CEO Lev Zaidenberg. “This certification greatly aids the company in its plans to become a significant provider of Natural Gas to the large market of small vehicles in the Philippines.”

He continued, “The accreditation process was a lengthy one, requiring Energtek to perform extensive field tests over a long period to prove the effectiveness of the CNG Lite(TM) conversion system. Now that our CNG Lite(TM) fuel system has been approved for commercial application, it can be used to supply a cheaper and cleaner motor fuel that provides benefits for the entire population.”

FormCap Corp. (FRMC) to Attain Bonded Operator Status in New Mexico

FormCap Corp. announced yesterday that it is establishing itself as a Bonded Operator in the State of New Mexico in anticipation of its first proposed well on the Weber City Prospect located in Curry County, New Mexico. The company holds 100% Working Interest in approximately 5,800 gross acres of oil & gas leases in the Permian Basin, all with primary terms of five (5) years. The Company’s operational partner, led by Calgary based Norman Mackenzie, has confirmed that the technical team is completing its deliberations and an initial well will be proposed soon.

The Weber City Prospect is strategically positioned in the Permian Basin. A prolific area that has produced over 35 billion barrels of oil and 100 trillion cubic feet of gas, and is host to over 20 percent of all domestic oil and gas produced in the US, the Permian Basin’s development history and stable, long-life production is one of the main reasons FormCap has secured the Weber City Prospect acreage and continues to expand its holdings. FormCap plans to drill wells to test four potentially productive hydrocarbon zones; the San Andres, Clearfork, Wolfcamp and Cisco formations. According to the company, over 125 wells (based on 40 acre spacing) could be drilled on the Prospect.

“As a Bonded Operator in New Mexico, FormCap will more fully control operations and production from our successful wells on the Weber City Prospect. This will minimize operational costs and maximize our profits over the long term,” stated Graham Douglas, FormCap’s President & CEO.

CitySide Tickets, Inc. (CIST) FOX Business Network Live Interview Now Available On-Demand

CitySide Tickets, Inc., which owns and operates CitySidetickets.com, a nationwide event ticket purchasing venue that caters to a diverse selection of popular theater, music, and sporting events, early this morning announced that CEO Michael DeAmicis’ interview with FOX Business is now available online at www.Video.QualityStocks.net.

During the live interview, Mr. DeAmicis discussed the company’s national expansion plan, his background and experience selling tickets, how his upbringing prepared him to start and operate a ticket business, various contacts in sports and music world, and the company’s competitive advantages and acquisition strategy, among other topics.


Sponsors of the Day


The QualityStocks Public Company Sponsor News



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336